Items where authors include "Lovgren, M.-L."

Article

Bageta, M.L., Lopez-Balboa, P., Bursnall, M. et al. (17 more authors) (2025) Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with recessive dystrophic epidermolysis bullosa (MissionEB): a randomised, double-blind, placebo controlled, crossover, phase 3 trial with an internal phase 1 dose de-escalation phase. EClinicalMedicine. 103417. ISSN 2589-5370

Bageta, M.L. orcid.org/0000-0002-0173-7923, López-Balboa, P. orcid.org/0000-0002-9944-719X, Dimairo, M. orcid.org/0000-0002-9311-6920 et al. (15 more authors) (2025) Mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: MissionEB protocol for a randomised, double-blinded, placebo-controlled, two-centre, crossover trial with an internal phase I dose de-escalation phase and open-label extension. BMJ Open, 15 (5). e089857. ISSN 2044-6055

Wan, M., Jones, A.P., Maskrey, D. et al. (27 more authors) (2025) Exposure–response of ciclosporin and methotrexate in children and young people with severe atopic dermatitis: A secondary analysis of the TREatment of severe Atopic dermatitis Trial (TREAT). Clinical and Experimental Dermatology. llaf147. ISSN 0307-6938

Bruce, G. orcid.org/0000-0003-4713-3647, Rosala-Hallas, A., Jones, A.P. et al. (28 more authors) (2024) The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children – results from the TREAT trial. British Journal of Dermatology, 191 (5). pp. 851-852. ISSN 0007-0963

Flohr, C. orcid.org/0000-0003-4884-6286, Rosala-Hallas, A., Jones, A.P. et al. (76 more authors) (2023) Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial. British Journal of Dermatology, 189 (6). pp. 674-684. ISSN 0007-0963